| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3133 |
| Trial ID | NCT05474885 |
| Disease | Systemic Lupus Erythematosus |
| Altered gene | BCMA|CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA/CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE) |
| Year | 2022 |
| Country | China |
| Company sponsor | iCell Gene Therapeutics |
| Other ID(s) | ICG180-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||